Page 5 - Litigation Release News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog:
An appellate court upheld a judgment that clever omissions from statements made by a corporate officer constituted securities fraud. On January 22, 2021, the U.S. Court of Appeals for the First Circuit in Boston, Massachusetts upheld a jury’s fraud verdict against an executive in a securities case tried in the U.S. District Court for the District of Massachusetts.
1  In a 30-page opinion, the Court in
SEC v. Johnston
2  refused to overturn a verdict finding that defendant David Johnston, the former chief financial officer of AVEO Pharmaceuticals, Inc., ....

United States , United Kingdom , Nate Raymond , William Slichenmyer , Don Seiffert , David Johnston , Michael Smith , David Pittman , Pharmaceuticals Appoints David Johnston , Drug Administration , Us Court , Us District Court , Exchange Commission , Pharmaceuticals Executives , Oncologic Drugs Advisory Committee , Panel Votes Down Two Cancer Drugs , Aveo Pharmaceuticals Inc , Securities Exchange , Pharmaceuticals Inc , First Circuit , Securities Exchange Act , Securities Act , Federal Drug Administration , Complete Response , Misleading Statements , Drugs Advisory Committee ,